Among prostate cancer patients, those with DNA mismatch repair mutations have particularly aggressive progression and reduced survivability. Though these tumors are more resistant to traditional treatment methods, a recent study has shown that they may be more susceptible to immunotherapy.
Browsing: Taxonomy > Genetics
A valuable cache of brain cancer biomedical data, termed REMBRANDT, has been made freely accessible to researchers worldwide.
Specific genes associated with triple-negative breast cancer risk have been identified by multigene hereditary cancer panel testing.
The largest ever study of its kind has become the first to definitively show an increased risk of blood cancers in relatives of patients.
A gene that’s associated with an autoimmune form of hair loss could be exploited to improve cancer immunotherapy, suggests a new mouse study.
A study has discovered the first genetic marker that can distinguish between aggressive versus benign bone tumors.
The prostate cancer test combines genetic variations linked to prostate cancer and identifies the 1% of men that are at high risk.
In a medical breakthrough, a new approach to immunotherapy has led to complete regression of breast cancer in a patient unresponsive to all other treatments.
A genomic study has demonstrated that individuals with tumors that have high-microsatellite instability (MSI-H) are more likely to have Lynch syndrome.